Treatment of Schizoaffective Disorder Using Mifepristone

Trial ID or NCT#

NCT00725270

Status

not recruiting iconNOT RECRUITING

Purpose

This study tests the hypothesis that mifepristone will diminish cognitive distortion and alleviate psychosis in patients with schizoaffective disorder.

Official Title

Treatment of Schizoaffective Disorder Using Mifepristone

Eligibility Criteria

Ages Eligible for Study: 18 Years to 75 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. The subjects will be 30 inpatients or outpatients with schizoaffective disorder.
Exclusion Criteria:
  1. Subjects must be between the ages of eighteen and seventy-five without major medical problems.

Investigator(s)

Hugh Brent Solvason PhD MD
Hugh Brent Solvason PhD MD
Psychiatrist
Clinical Professor, Psychiatry and Behavioral Sciences
Jennifer Keller
Jennifer Keller
Psychologist
Clinical Professor, Psychiatry and Behavioral Sciences

Contact us to find out if this trial is right for you.

Contact

Jessica Hawkins
6507238323